Should you buy Commonwealth Bank of Australia, Scentre Group Ltd and CSL Limited?

Is now the right time to add these 3 stocks to your portfolio? Commonwealth Bank of Australia (ASX:CBA), Scentre Group Ltd (ASX:SCG) and CSL Limited (ASX:CSL).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Commonwealth Bank of Australia

Results released this week by Commonwealth Bank of Australia (ASX: CBA) were positive and showed that the bank is making good progress with regards to its bottom line growth. For example, cash earnings came in 8% higher than in the first half of the previous year, with dividends per share increasing by the same amount year-on-year. However, while the results were slightly ahead of market expectations, shares in the bank closed down almost 1% on the day.

Of course, CBA remains a highly appealing stock to own at the present time. Certainly, its valuation is rather rich, with it having a price to earnings (P/E) ratio of 16.6 for example. But, when you consider that it has increased its bottom line at an annualised rate of 11.6% over the last five years, and is forecast to do so by 6.1% per annum in the next two years, it appears to be a solid, long term investment that could see its rating move higher. As such, now could be a good time to buy a slice of it.

Scentre Group Ltd

The operator of Westfield's Australian and New Zealand assets, Scentre Group Ltd (ASX: SCG) may appear to be a rather richly valued stock at the present time. That's because it has a P/E ratio of 18 which, when the ASX has a P/E ratio of 15.9, seems to be rather high.

However, Scentre continues to offer investors an appealing mix of income and growth prospects. For example, it currently yields a very enticing 5.2% and this could increase in appeal should interest rates move lower, thereby helping to push Scentre's share price higher. And, with there being scope for higher levels of consumer spending moving forward owing to a loose monetary policy, Scentre's earnings growth forecast of 7.3% per annum over the next two years could be subject to an upgrade.

As a result, now could be a great time to add Scentre to your portfolio.

CSL Limited

Shares in CSL Limited (ASX: CSL) slumped by around 8% yesterday, as the pharmaceutical company reduced its profit guidance for the full-year. The main reasons for this were increased demand for cheaper products and tight government spending, although CSL is still expected to increase its bottom line by 10% in the current year.

That's an impressive rate of growth and, looking ahead, its share price could move higher due to it offering above-average growth prospects at a very reasonable price. For example, CSL has a price to earnings growth (PEG) ratio of just 1.3 which, when the ASX has a PEG ratio of 2.1, indicates that its share price could still perform well in the medium to long term.

Therefore, while market sentiment may decline somewhat in the short term, CSL remains an excellent long-term investment.

Motley Fool contributor Peter Stephens does not own shares in any of the companies mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »